search
Back to results

Monitoring Patients With Shortness of Breath With Repeated Ultrasound Examinations (MODUS)

Primary Purpose

Dyspnea

Status
Completed
Phase
Not Applicable
Locations
Denmark
Study Type
Interventional
Intervention
Focused ultrasound of the lungs (FLUS) and focused cardiac ultrasound (FoCUS)
Standard care
Sponsored by
Slagelse Hospital
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Dyspnea focused on measuring Dyspnea, Ultrasound, Point-of-care, Focused, Serial, Monitoring

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Participants should be 18 years or older
  • Presented at the ED with shortness of breath (asking the patient upon arrival in the triage what their primary complaint is for a referral to an emergency department)
  • Written informed consent obtained from the patient

Exclusion Criteria:

  • Patients with dyspnea primary admitted because of a trauma

Sites / Locations

  • Department of Emergency Medicine
  • Department of Emergency Medicine

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Serial ultrasound group

Standard care group

Arm Description

Will received standard care and monitoring and in addition, have focused ultrasound examination of the heart and the lungs done twice. The investigator is supposed to titrate the treatment according to the findings on the ultrasound examinations.

Standard care and monitoring.

Outcomes

Primary Outcome Measures

Change in dyspnea severity on a verbal dyspnea scale (VDS) from 0-10
Self reported severity of dyspnea. 0 = no dyspnea. 10 = worst dyspnea ever.

Secondary Outcome Measures

Lenght of stay
Number of days the patients is admitted.
Number of readmission(s)
Number of times the patients is readmitted after discharge.
In-hospital all-cause mortality
Number of patients who dies under the admission
All-cause mortality after discharge
Number of patients who dies after discharge.
IVC-CI (inferior vena cava collapsibility index) correlated to vital signs and VDS
B-line count correlated to vital signs and VDS
The changes in IVC-CI between the ultrasound examinations
The changes in B-line count between the ultrasound examinations

Full Information

First Posted
September 5, 2019
Last Updated
October 5, 2021
Sponsor
Slagelse Hospital
Collaborators
Odense University Hospital, Holbaek Sygehus, Zealand University Hospital, Horsens Hospital, Herning Hospital, Hvidovre University Hospital
search

1. Study Identification

Unique Protocol Identification Number
NCT04091334
Brief Title
Monitoring Patients With Shortness of Breath With Repeated Ultrasound Examinations
Acronym
MODUS
Official Title
Monitoring Patients With Acute Dyspnea With Serial Focused Ultrasound of the Heart and the Lungs
Study Type
Interventional

2. Study Status

Record Verification Date
October 2021
Overall Recruitment Status
Completed
Study Start Date
October 9, 2019 (Actual)
Primary Completion Date
March 22, 2021 (Actual)
Study Completion Date
March 22, 2021 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Slagelse Hospital
Collaborators
Odense University Hospital, Holbaek Sygehus, Zealand University Hospital, Horsens Hospital, Herning Hospital, Hvidovre University Hospital

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Purpose of the study: The purpose of the trial is to investigate whether repeated ultrasound scans of the heart and lungs of patients with shortness of breath may help to optimize their treatment. This patient group is characterized by an extended hospitalization and a high mortality rate. Therefore, it is essential to be able to target the treatment in order to shorten length of stay, prevent readmissions, and improve survival in these patients. Ultrasound scanning used in this way is novel. The study method: Initially, all patients will receive standard evaluation and ultrasound of the heart and the lungs. Then the patients are randomly assigned into two groups. In one group, patients receive standard assessment and treatment. In the second group, the patients, in addition to standard examination and treatment, receive ultrasound scans of their heart and lungs after two hours and again fire hours after the first scan. After discharge, the subjects are followed for one year to evaluate what examinations and treatment they received during hospitalization, whether they have been readmitted or died.
Detailed Description
Design: Multicenter, randomized, controlled, open-label, and pragmatic trial. Settings: Several different emergency departments (EDs) in Denmark. Study flow: After arrival, the patients are screened according to eligibility criteria. If patients meet the inclusion criteria and informed consent is obtained, the patients are randomly assigned to one of two groups. In both groups, the patients received standard evaluation, e.g., blood samples, physical examination, arterial blood gas, and in addition ultrasound examination of the heart and the lungs. In the intervention group, the patients are further examined with serial ultrasound scans of the heart and the lungs after two and four hours after the initial evaluation. In the course of admittance, the patients will have there baseline characteristics recorded together with the ultrasound findings, symptoms, and vitals. Symptoms will be recorded at a verbal dyspnea symptom scale (VDS) from 0-10. All data will be registered at the same time points to make comparisons: At 1, 2, 4 and after 5 hours. Sample size: This is calculated from the primary outcome and with an assumption of a power of 80%, type 1-error of 5%, and 10% dropouts. The calculations are based on previous studies using the VDS on patients with acute dyspnea. The sample size is 103 patients in each group. Statistical analysis: Baseline characteristics will be summarized and divided into the intervention and control group. Continuous variables will be summarized as means and standard deviation (SD) or medians and interquartile range (IQR) depending on the distribution of the variable. For categorical variables, frequencies and percentages will be reported. The primary outcome - change in dyspnea on VDS - will be compared between the two groups to detect any difference. Pairwise comparisons of VDS will be made at the same time points in both groups. The secondary outcomes: Length of stay, death, and the number of readmissions will be compared between the two groups to detect a difference. Time-to-event (dead or readmission) will be visualized with Kaplan Meier curves. In the case of lost to follow-up or other reasons for missing data both intention-to-treat and per-protocol analysis will be used. The secondary outcomes in the interventions group: The dynamic changes in inferior vena cava collapsibility index (IVC-CI) and the sum of B-lines will be expressed as means and SD or median and IQR depending on the distribution of the data and compared between the different time points. Furthermore, IVC-CI and the sum of B-lines will be compared to vitals and VDS-score to detect a correlation. The inter- and intraobserver variability regarding the focused ultrasound will be accessed. Data management: The registered data on each patient will be recorded and securely stored in an encrypted, logged, and password-protected database called REDCap. All adjustments in the database are logged. The patients are anonymized.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Dyspnea
Keywords
Dyspnea, Ultrasound, Point-of-care, Focused, Serial, Monitoring

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
206 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Serial ultrasound group
Arm Type
Experimental
Arm Description
Will received standard care and monitoring and in addition, have focused ultrasound examination of the heart and the lungs done twice. The investigator is supposed to titrate the treatment according to the findings on the ultrasound examinations.
Arm Title
Standard care group
Arm Type
Active Comparator
Arm Description
Standard care and monitoring.
Intervention Type
Device
Intervention Name(s)
Focused ultrasound of the lungs (FLUS) and focused cardiac ultrasound (FoCUS)
Intervention Description
FLUS: Scanning 8 zones of the front and lateral of the thorax. Record number of B-lines, consolidations, pneumothorax, pleural effusions. FoCUS: Scan the heart in different views and record the ejection fraction, size of the right side of the heart, pericardial effusion, tricuspid annular plane systolic excursion (TAPSE), inferior vena cava (IVC) diameter, and IVC collapsibility Index (IVC-CI).
Intervention Type
Other
Intervention Name(s)
Standard care
Intervention Description
Standard care and evaluation and monitoring
Primary Outcome Measure Information:
Title
Change in dyspnea severity on a verbal dyspnea scale (VDS) from 0-10
Description
Self reported severity of dyspnea. 0 = no dyspnea. 10 = worst dyspnea ever.
Time Frame
Assessed within 1 hour from arrival, again after two, four hours and five hours
Secondary Outcome Measure Information:
Title
Lenght of stay
Description
Number of days the patients is admitted.
Time Frame
Assessed after 30 days from inclusion of the last patient.
Title
Number of readmission(s)
Description
Number of times the patients is readmitted after discharge.
Time Frame
Assessed up to 12 months from inclusion of the last patient.
Title
In-hospital all-cause mortality
Description
Number of patients who dies under the admission
Time Frame
Assessed after 30 days from inclusion of the last patient.
Title
All-cause mortality after discharge
Description
Number of patients who dies after discharge.
Time Frame
Assessed up to 12 months from inclusion of the last patient.
Title
IVC-CI (inferior vena cava collapsibility index) correlated to vital signs and VDS
Time Frame
Assessed within 1 hour from arrival, again after two, four hours and five hours
Title
B-line count correlated to vital signs and VDS
Time Frame
Assessed within 1 hour from arrival, again after two, four hours and five hours
Title
The changes in IVC-CI between the ultrasound examinations
Time Frame
Assessed within 1 hour from arrival, again after two, four hours and five hours
Title
The changes in B-line count between the ultrasound examinations
Time Frame
Assessed within 1 hour from arrival, again after two, four hours and five hours

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Participants should be 18 years or older Presented at the ED with shortness of breath (asking the patient upon arrival in the triage what their primary complaint is for a referral to an emergency department) Written informed consent obtained from the patient Exclusion Criteria: Patients with dyspnea primary admitted because of a trauma
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Michael D. Arvig, MD
Organizational Affiliation
Dept. of Emergency Medicine, Slagelse Hospital
Official's Role
Principal Investigator
Facility Information:
Facility Name
Department of Emergency Medicine
City
Slagelse
State/Province
Region Zealand
ZIP/Postal Code
4200
Country
Denmark
Facility Name
Department of Emergency Medicine
City
Horsens
Country
Denmark

12. IPD Sharing Statement

Plan to Share IPD
Yes
IPD Sharing Plan Description
Raw data (deidentified participant data) may be made available upon request to the corresponding author.
IPD Sharing Time Frame
Data will be available within 6 months from the completion of the trial.
IPD Sharing Access Criteria
Data can be made available if data sharing is in accordance with applicable legislation on the processing of personal data (The General Data Protection Regulation (GDPR)) and Danish Act on Data Protection. Data will be provided through a secured mailing address. Data can only be reused after acceptance from the project manager.
Citations:
PubMed Identifier
22387754
Citation
Mockel M, Searle J, Muller R, Slagman A, Storchmann H, Oestereich P, Wyrwich W, Ale-Abaei A, Vollert JO, Koch M, Somasundaram R. Chief complaints in medical emergencies: do they relate to underlying disease and outcome? The Charite Emergency Medicine Study (CHARITEM). Eur J Emerg Med. 2013 Apr;20(2):103-8. doi: 10.1097/MEJ.0b013e328351e609.
Results Reference
background
PubMed Identifier
16723034
Citation
Ray P, Birolleau S, Lefort Y, Becquemin MH, Beigelman C, Isnard R, Teixeira A, Arthaud M, Riou B, Boddaert J. Acute respiratory failure in the elderly: etiology, emergency diagnosis and prognosis. Crit Care. 2006;10(3):R82. doi: 10.1186/cc4926. Epub 2006 May 24.
Results Reference
background
PubMed Identifier
30817792
Citation
Lindskou TA, Pilgaard L, Sovso MB, Klojgard TA, Larsen TM, Jensen FB, Weinrich UM, Christensen EF. Symptom, diagnosis and mortality among respiratory emergency medical service patients. PLoS One. 2019 Feb 28;14(2):e0213145. doi: 10.1371/journal.pone.0213145. eCollection 2019.
Results Reference
background
PubMed Identifier
20354029
Citation
Gheorghiade M, Follath F, Ponikowski P, Barsuk JH, Blair JE, Cleland JG, Dickstein K, Drazner MH, Fonarow GC, Jaarsma T, Jondeau G, Sendon JL, Mebazaa A, Metra M, Nieminen M, Pang PS, Seferovic P, Stevenson LW, van Veldhuisen DJ, Zannad F, Anker SD, Rhodes A, McMurray JJ, Filippatos G; European Society of Cardiology; European Society of Intensive Care Medicine. Assessing and grading congestion in acute heart failure: a scientific statement from the acute heart failure committee of the heart failure association of the European Society of Cardiology and endorsed by the European Society of Intensive Care Medicine. Eur J Heart Fail. 2010 May;12(5):423-33. doi: 10.1093/eurjhf/hfq045. Epub 2010 Mar 30.
Results Reference
background
PubMed Identifier
25654562
Citation
Pivetta E, Goffi A, Lupia E, Tizzani M, Porrino G, Ferreri E, Volpicelli G, Balzaretti P, Banderali A, Iacobucci A, Locatelli S, Casoli G, Stone MB, Maule MM, Baldi I, Merletti F, Cibinel GA, Baron P, Battista S, Buonafede G, Busso V, Conterno A, Del Rizzo P, Ferrera P, Pecetto PF, Moiraghi C, Morello F, Steri F, Ciccone G, Calasso C, Caserta MA, Civita M, Condo' C, D'Alessandro V, Del Colle S, Ferrero S, Griot G, Laurita E, Lazzero A, Lo Curto F, Michelazzo M, Nicosia V, Palmari N, Ricchiardi A, Rolfo A, Rostagno R, Bar F, Boero E, Frascisco M, Micossi I, Mussa A, Stefanone V, Agricola R, Cordero G, Corradi F, Runzo C, Soragna A, Sciullo D, Vercillo D, Allione A, Artana N, Corsini F, Dutto L, Lauria G, Morgillo T, Tartaglino B, Bergandi D, Cassetta I, Masera C, Garrone M, Ghiselli G, Ausiello L, Barutta L, Bernardi E, Bono A, Forno D, Lamorte A, Lison D, Lorenzati B, Maggio E, Masi I, Maggiorotto M, Novelli G, Panero F, Perotto M, Ravazzoli M, Saglio E, Soardo F, Tizzani A, Tizzani P, Tullio M, Ulla M, Romagnoli E; SIMEU Group for Lung Ultrasound in the Emergency Department in Piedmont. Lung Ultrasound-Implemented Diagnosis of Acute Decompensated Heart Failure in the ED: A SIMEU Multicenter Study. Chest. 2015 Jul;148(1):202-210. doi: 10.1378/chest.14-2608.
Results Reference
background
PubMed Identifier
23747642
Citation
Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE Jr, Drazner MH, Fonarow GC, Geraci SA, Horwich T, Januzzi JL, Johnson MR, Kasper EK, Levy WC, Masoudi FA, McBride PE, McMurray JJ, Mitchell JE, Peterson PN, Riegel B, Sam F, Stevenson LW, Tang WH, Tsai EJ, Wilkoff BL; American College of Cardiology Foundation; American Heart Association Task Force on Practice Guidelines. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2013 Oct 15;62(16):e147-239. doi: 10.1016/j.jacc.2013.05.019. Epub 2013 Jun 5. No abstract available.
Results Reference
background
PubMed Identifier
27894487
Citation
Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS, Falk V, Gonzalez-Juanatey JR, Harjola VP, Jankowska EA, Jessup M, Linde C, Nihoyannopoulos P, Parissis JT, Pieske B, Riley JP, Rosano GMC, Ruilope LM, Ruschitzka F, Rutten FH, van der Meer P. 2016 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure. Rev Esp Cardiol (Engl Ed). 2016 Dec;69(12):1167. doi: 10.1016/j.rec.2016.11.005. No abstract available. Erratum In: Rev Esp Cardiol (Engl Ed). 2017 Apr;70(4):309-310. English, Spanish.
Results Reference
background
PubMed Identifier
24993976
Citation
Gargani L, Volpicelli G. How I do it: lung ultrasound. Cardiovasc Ultrasound. 2014 Jul 4;12:25. doi: 10.1186/1476-7120-12-25.
Results Reference
background
PubMed Identifier
22392031
Citation
Volpicelli G, Elbarbary M, Blaivas M, Lichtenstein DA, Mathis G, Kirkpatrick AW, Melniker L, Gargani L, Noble VE, Via G, Dean A, Tsung JW, Soldati G, Copetti R, Bouhemad B, Reissig A, Agricola E, Rouby JJ, Arbelot C, Liteplo A, Sargsyan A, Silva F, Hoppmann R, Breitkreutz R, Seibel A, Neri L, Storti E, Petrovic T; International Liaison Committee on Lung Ultrasound (ILC-LUS) for International Consensus Conference on Lung Ultrasound (ICC-LUS). International evidence-based recommendations for point-of-care lung ultrasound. Intensive Care Med. 2012 Apr;38(4):577-91. doi: 10.1007/s00134-012-2513-4. Epub 2012 Mar 6.
Results Reference
background
PubMed Identifier
26038013
Citation
Kelly N, Esteve R, Papadimos TJ, Sharpe RP, Keeney SA, DeQuevedo R, Portner M, Bahner DP, Stawicki SP. Clinician-performed ultrasound in hemodynamic and cardiac assessment: a synopsis of current indications and limitations. Eur J Trauma Emerg Surg. 2015 Oct;41(5):469-80. doi: 10.1007/s00068-014-0492-6. Epub 2015 Jan 8.
Results Reference
background
PubMed Identifier
27857946
Citation
Gaskamp M, Blubaugh M, McCarthy LH, Scheid DC. Can Bedside Ultrasound Inferior Vena Cava Measurements Accurately Diagnose Congestive Heart Failure in the Emergency Department? A Clin-IQ. J Patient Cent Res Rev. 2016 Fall-Winter;3(4):230-234. Epub 2016 Nov 11.
Results Reference
background
PubMed Identifier
19041537
Citation
Blehar DJ, Dickman E, Gaspari R. Identification of congestive heart failure via respiratory variation of inferior vena cava diameter. Am J Emerg Med. 2009 Jan;27(1):71-75. doi: 10.1016/j.ajem.2008.01.002.
Results Reference
background
PubMed Identifier
18534289
Citation
Volpicelli G, Caramello V, Cardinale L, Mussa A, Bar F, Frascisco MF. Bedside ultrasound of the lung for the monitoring of acute decompensated heart failure. Am J Emerg Med. 2008 Jun;26(5):585-91. doi: 10.1016/j.ajem.2007.09.014.
Results Reference
background
PubMed Identifier
22858877
Citation
Via G, Storti E, Gulati G, Neri L, Mojoli F, Braschi A. Lung ultrasound in the ICU: from diagnostic instrument to respiratory monitoring tool. Minerva Anestesiol. 2012 Nov;78(11):1282-96. Epub 2012 Aug 3.
Results Reference
background
PubMed Identifier
27061502
Citation
Martindale JL. Resolution of sonographic B-lines as a measure of pulmonary decongestion in acute heart failure. Am J Emerg Med. 2016 Jun;34(6):1129-32. doi: 10.1016/j.ajem.2016.03.043. Epub 2016 Mar 19.
Results Reference
background
PubMed Identifier
23040115
Citation
Ramasubbu K, Deswal A, Chan W, Aguilar D, Bozkurt B. Echocardiographic changes during treatment of acute decompensated heart failure: insights from the ESCAPE trial. J Card Fail. 2012 Oct;18(10):792-8. doi: 10.1016/j.cardfail.2012.08.358.
Results Reference
background
PubMed Identifier
27026172
Citation
Asahi T, Nakata M, Higa N, Manita M, Tabata K, Shimabukuro M. Respiratory Collapse of the Inferior Vena Cava Reflects Volume Shift and Subsequent Fluid Refill in Acute Heart Failure Syndrome. Circ J. 2016 Apr 25;80(5):1171-7. doi: 10.1253/circj.CJ-15-1374. Epub 2016 Mar 29.
Results Reference
background
PubMed Identifier
24368354
Citation
Ferrada P, Evans D, Wolfe L, Anand RJ, Vanguri P, Mayglothling J, Whelan J, Malhotra A, Goldberg S, Duane T, Aboutanos M, Ivatury RR. Findings of a randomized controlled trial using limited transthoracic echocardiogram (LTTE) as a hemodynamic monitoring tool in the trauma bay. J Trauma Acute Care Surg. 2014 Jan;76(1):31-7; discussion 37-8. doi: 10.1097/TA.0b013e3182a74ad9.
Results Reference
background
PubMed Identifier
24629744
Citation
Yavasi O, Unluer EE, Kayayurt K, Ekinci S, Saglam C, Surum N, Koseoglu MH, Yesil M. Monitoring the response to treatment of acute heart failure patients by ultrasonographic inferior vena cava collapsibility index. Am J Emerg Med. 2014 May;32(5):403-7. doi: 10.1016/j.ajem.2013.12.046. Epub 2014 Jan 3.
Results Reference
background
PubMed Identifier
24897939
Citation
Tchernodrinski S, Lucas BP, Athavale A, Candotti C, Margeta B, Katz A, Kumapley R. Inferior vena cava diameter change after intravenous furosemide in patients diagnosed with acute decompensated heart failure. J Clin Ultrasound. 2015 Mar;43(3):187-93. doi: 10.1002/jcu.22173. Epub 2014 Jun 4.
Results Reference
background
PubMed Identifier
26337295
Citation
Gargani L, Pang PS, Frassi F, Miglioranza MH, Dini FL, Landi P, Picano E. Persistent pulmonary congestion before discharge predicts rehospitalization in heart failure: a lung ultrasound study. Cardiovasc Ultrasound. 2015 Sep 4;13:40. doi: 10.1186/s12947-015-0033-4.
Results Reference
background
PubMed Identifier
28271386
Citation
Spevack R, Al Shukairi M, Jayaraman D, Dankoff J, Rudski L, Lipes J. Serial lung and IVC ultrasound in the assessment of congestive heart failure. Crit Ultrasound J. 2017 Dec;9(1):7. doi: 10.1186/s13089-017-0062-3. Epub 2017 Mar 7.
Results Reference
background
PubMed Identifier
20136641
Citation
Saracino A, Weiland TJ, Jolly B, Dent AW. Verbal dyspnoea score predicts emergency department departure status in patients with shortness of breath. Emerg Med Australas. 2010 Feb;22(1):21-9. doi: 10.1111/j.1742-6723.2009.01254.x. Epub 2010 Feb 4.
Results Reference
background
PubMed Identifier
19125825
Citation
Saracino A, Weiland T, Dent A, Jolly B. Validation of a verbal dyspnoea rating scale in the emergency department. Emerg Med Australas. 2008 Dec;20(6):475-81. doi: 10.1111/j.1742-6723.2008.01132.x.
Results Reference
background
PubMed Identifier
24951446
Citation
Via G, Hussain A, Wells M, Reardon R, ElBarbary M, Noble VE, Tsung JW, Neskovic AN, Price S, Oren-Grinberg A, Liteplo A, Cordioli R, Naqvi N, Rola P, Poelaert J, Gulic TG, Sloth E, Labovitz A, Kimura B, Breitkreutz R, Masani N, Bowra J, Talmor D, Guarracino F, Goudie A, Xiaoting W, Chawla R, Galderisi M, Blaivas M, Petrovic T, Storti E, Neri L, Melniker L; International Liaison Committee on Focused Cardiac UltraSound (ILC-FoCUS); International Conference on Focused Cardiac UltraSound (IC-FoCUS). International evidence-based recommendations for focused cardiac ultrasound. J Am Soc Echocardiogr. 2014 Jul;27(7):683.e1-683.e33. doi: 10.1016/j.echo.2014.05.001.
Results Reference
background
PubMed Identifier
32499263
Citation
Arvig MD, Lassen AT, Gaede PH, Laursen CB. Monitoring patients with acute dyspnoea with a serial focused ultrasound of the heart and the lungs (MODUS): a protocol for a multicentre, randomised, open-label, pragmatic and controlled trial. BMJ Open. 2020 Jun 3;10(6):e034373. doi: 10.1136/bmjopen-2019-034373.
Results Reference
derived

Learn more about this trial

Monitoring Patients With Shortness of Breath With Repeated Ultrasound Examinations

We'll reach out to this number within 24 hrs